Add BrightSurf on Google Email

Brigham and Women's Hospital


Predicting cancers' cell of origin

A study by Brigham and Women's Hospital researchers uses epigenomic maps to predict a cancer's cell type of origin, providing new insights into early cancer events. This discovery could help guide treatment decisions for patients with unknown primary sites, which pose significant challenges.

SourceBrigham and Women's Hospital·JournalNature·DateFeb 18, 2015

Tobacco cessation outreach to disadvantaged smokers

Researchers identify a proactive approach to help low-SES smokers quit smoking, with telephone-based motivational counseling and free nicotine replacement therapy increasing quit rates. The study found that community resources, such as physical activity and job counseling referrals, were crucial in promoting tobacco cessation.

SourceBrigham and Women's Hospital·JournalJAMA Internal Medicine·DateDec 15, 2014

Sopping up proteins with thermosponges

The study demonstrates that thermosponge nanoparticles can effectively deliver a variety of proteins while preserving their biological activity. The new platform is designed to eliminate the need for harsh solvents and shows promise for delivering protein-based drugs for human therapeutics.

SourceBrigham and Women's Hospital·JournalNano Letters·DateOct 22, 2014

DNA methylation involved in Alzheimer's disease

Researchers at Brigham and Women's Hospital discovered that early changes in brain DNA methylation are involved in Alzheimer's disease. The study found correlations between methylation levels and Alzheimer's disease in specific genes, suggesting a potential role for epigenomic modifications in disease susceptibility.

SourceBrigham and Women's Hospital·JournalNature Neuroscience·DateAug 17, 2014

Clearing cells to prevent cervical cancer

Researchers found a significant reduction in cervical cancer risk after removing squamocolumnar junction (SCJ) cells, which are implicated as the origins of cervical cancer. The study showed that removal of SCJ cells altered recurrence patterns and may prevent precancerous growths.

SourceBrigham and Women's Hospital·JournalInternational Journal of Cancer·DateJul 25, 2014

Changes in generic pill color and shape disrupt use

Researchers found that variation in generic drug appearance is associated with a greater risk of patients stopping their essential post-heart attack medications. Changes in pill color and shape are linked to increased odds of non-adherence, highlighting the need for healthcare professionals to warn patients about potential changes.

SourceBrigham and Women's Hospital·JournalAnnals of Internal Medicine·DateJul 14, 2014

When good gut bacteria get sick

A study from Brigham and Women's Hospital found that infection can significantly alter the gut microbiota, leading to new microbial signatures that may help detect early stages of inflammation. These findings could aid in better treatment and prevention of gastrointestinal infections and inflammation.

SourceBrigham and Women's Hospital·JournalPLOS ONE·DateJul 11, 2014

Six cases where big data can reduce healthcare costs

A new study outlines opportunities to reduce healthcare costs through the use of big data. Researchers highlight five key areas: high-cost patients, readmissions, triage, decompensation, and adverse events. By analyzing large datasets, clinicians can identify high-risk patients, predict readmissions, and optimize treatment for chronic ...

SourceBrigham and Women's Hospital·JournalHealth Affairs·DateJul 8, 2014

Building a better blood vessel

Researchers at Brigham and Women's Hospital have successfully fabricated blood vessels using 3D bioprinting technology, addressing a critical challenge in tissue engineering. The approach involves printing agarose fibers that become the blood vessel channels, allowing for physical removal of template layers and improved cell viability.

SourceBrigham and Women's Hospital·JournalLab on a Chip·DateMay 30, 2014